Detalle Publicación


Vaccination for Pancreatic Ductal Adenocarcinoma: A Hard Nut to Crack

Título de la revista: CLINICAL CANCER RESEARCH
ISSN: 1078-0432
Volumen: 25
Número: 18
Páginas: 5435 - 5437
Fecha de publicación: 2019
No immunotherapy strategy is yet offering consistent results against pancreatic ductal adenocarcinoma. A randomized clinical trial testing repeated immunization with a Listeria monocytogenes-based vaccine encoding for mesothelin in combination with a GM-CSF-transfected allogeneic pancreatic cell vaccine reports no survival benefit for the vaccinated patients.